BioPharma Credit under increased pressure to reinvest its cash pile after shares in Lexicon, one of the high-yielding fund's borrowers, plunged, raising doubts over its future.
Peter Walls of Unicorn Mastertrust has added to a stake in Woodford Patient Capital Trust and backed activist trust Crystal Amber after Neil Woodford sold out last month.
Peter Hewitt, the investment trust picker at BMO Managed Portfolio, has a close eye on Neil Woodford and Alexander Darwall as both fund managers go through very different periods of uncertainty.
Global multi-manager trust has hired Hermes Investment Management to help it ramp up engagement with companies on environmental, social and governance issues.
Athelney founder Robin Boyle abandons attempt to take UK smaller company minnow to Gresham House after settling a row with the £5 million trust's largest shareholder.
Suspended Woodford Equity Income fund breaches limit on unquoted stocks after manager's shares in Benevolent AI and Industrial Heat delisted from Guernsey's stock exchange.
The turnaround at Artemis' ‘best ideas’ fund continues to be postponed after a shake-up of its investment policy last year failed to immediately revive the portfolio.
Fund manager Geoff Hsu shares investor 'frustration' with performance but pledges to get the trust back on track, with some help from China's evolving pharmaceuticals market.
Dale Nicholls, manager of Fidelity Special Situations, says unlisted investments are a 'key source of alpha' or outperformance for the trust.
UK's oldest investment trust enjoys strongest first-half in over 20 years but private equity exposure and weakening share price see F&C lag its benchmark.